Intellectual Property Reform concerning bio-pharmaceutical industry Proposed policies regarding corporate tax reform - regarding all bio-pharmaceutical related provisions Trade-Related Aspects of Intellectual Property (TRIPS) Waiver. No related bill number Issues related to the 340B Drug Pricing Program - regarding all bio-pharmaceutical related provisions Issues related to the Inflation Reduction Act of 2022 IRA implementation HR 1319, American Rescue Plan Act of 2021 - regarding all bio-pharmaceutical related provisions S 464/HR 2163, Safe Step Act - regarding all bio-pharmaceutical related provisions Discussions regarding health equity PBM reform including S.4293, Pharmacy Benefit Manager Transparency Act of 2022 H.R.485, Protecting Health Care for All Patients of 2023 Act H.R.830, HELP Copays Act of 2023
CPT - Copyright/Patent/Trademark TAX - Taxation/Internal Revenue Code TRD - Trade (domestic/foreign) MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BRISTOL-MYERS SQUIBB COMPANY
801 Pennsylvania Ave, NW, Suite 745, WASHINGTON, DC, 20004, US
LANE PENRY JEFFREY LAST JOHN DEOUDES RICARDO SANCHEZ ORTEGON PAUL ANTHONY WILLIAMS CAROLINE TUCKER RICARDO SANCHEZ ORTEGON STEPHANIE A. DYSON LANE PENRY PAUL ANTHONY WILLIAMS JOHN DEOUDES STEPHANIE A. DYSON THOMAS BRUNET JEFFREY LAST RICARDO SANCHEZ ORTEGON KATHRYN NOVARIA LANE PENRY PAUL ANTHONY WILLIAMS